PATENT CLAIM ANALYSIS

Application Number: 15862751
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "252040"]

Abstract:
Disclosed herein are compositions and methods for treatment of spinal muscular atrophy (SMA). In certain embodiments, compounds are provided that increase full-length survival of motor neuron (SMN) protein production by an SMN2 gene.

Claim (Index 17):
The method as set forth in  claim 1 , wherein the compound is

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.14286
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15440727', '13941099', '15248052', '14369294', '14377531']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7866792664825534
- 35 USC 102 Novelty (BERT): 0.5950277255980532
- Combined Prediction Score: 0.7675141123941034
- Mean Citation Score: 412.023466
- Max Citation Score: 621.4379
- Similarity Product: 389.5814304285586

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test